XML 17 R6.htm IDEA: XBRL DOCUMENT v3.24.3
Condensed Consolidated Statements of Changes in Shareholders' Equity (unaudited) - USD ($)
$ in Thousands
Total
Ordinary shares
Additional paid-in capital
Treasury stock
Accumulated deficit
Accumulated other comprehensive income (loss)
Accumulated currency translation effect
Beginning balance (in shares) at Dec. 31, 2022   94,137,145          
Beginning balance at Dec. 31, 2022 $ 194,453 $ 10,720 $ 458,221 $ (1,109) $ (259,578) $ 781 $ (14,581)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net (loss) (20,561)       (20,561)    
Other comprehensive income (loss) 3,584         (82) 3,666
Issuance of ordinary shares (in shares)   10,174          
Issuance of ordinary shares 0 $ 1 (1)        
Treasury shares (14)     (14)      
Share-based payments 1,632   1,632        
Other change in equity 0            
Ending balance (in shares) at Mar. 31, 2023   94,147,319          
Ending balance at Mar. 31, 2023 179,094 $ 10,721 459,852 (1,123) (280,138) 698 (10,915)
Beginning balance (in shares) at Dec. 31, 2022   94,137,145          
Beginning balance at Dec. 31, 2022 194,453 $ 10,720 458,221 (1,109) (259,578) 781 (14,581)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net (loss) (61,540)            
Ending balance (in shares) at Sep. 30, 2023   96,253,553          
Ending balance at Sep. 30, 2023 143,991 $ 10,953 376,249 (1,163) (227,676) 761 (15,132)
Beginning balance (in shares) at Mar. 31, 2023   94,147,319          
Beginning balance at Mar. 31, 2023 179,094 $ 10,721 459,852 (1,123) (280,138) 698 (10,915)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net (loss) (24,243)       (24,243)    
Other comprehensive income (loss) (232)         (10) (221)
Issuance of ordinary shares (in shares)   2,103,635          
Issuance of ordinary shares 7,766 $ 231 7,535        
Issuance of warrants 0            
Treasury shares 42     42      
Share-based payments 1,814   1,814        
Allocation of accumulated net losses 0   (93,441)   93,441    
Ending balance (in shares) at Jun. 30, 2023   96,250,954          
Ending balance at Jun. 30, 2023 164,240 $ 10,952 375,759 (1,082) (210,940) 687 (11,136)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net (loss) (16,736)       (16,736)    
Other comprehensive income (loss) (3,922)         73 (3,996)
Issuance of ordinary shares (in shares)   2,599          
Issuance of ordinary shares (864) $ 1 (864)        
Issuance of warrants 0            
Treasury shares (81)     (81)      
Share-based payments 1,354   1,354        
Other change in equity 0            
Ending balance (in shares) at Sep. 30, 2023   96,253,553          
Ending balance at Sep. 30, 2023 143,991 $ 10,953 376,249 (1,163) (227,676) 761 (15,132)
Beginning balance (in shares) at Dec. 31, 2023   96,431,770          
Beginning balance at Dec. 31, 2023 140,187 $ 10,972 377,468 (1,263) (238,862) 742 (8,871)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net (loss) (27,345)       (27,345)    
Other comprehensive income (loss) (3,084)         (59) (3,026)
Issuance of ordinary shares (in shares)   2,599          
Issuance of ordinary shares 0            
Treasury shares (62)     (62)      
Share-based payments 1,958   1,958        
Ending balance (in shares) at Mar. 31, 2024   96,434,369          
Ending balance at Mar. 31, 2024 111,654 $ 10,972 379,426 (1,325) (266,207) 683 (11,897)
Beginning balance (in shares) at Dec. 31, 2023   96,431,770          
Beginning balance at Dec. 31, 2023 140,187 $ 10,972 377,468 (1,263) (238,862) 742 (8,871)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net (loss) (90,903)            
Ending balance (in shares) at Sep. 30, 2024   96,501,526          
Ending balance at Sep. 30, 2024 54,034 $ 10,979 316,102 (1,351) (263,332) 709 (9,073)
Beginning balance (in shares) at Mar. 31, 2024   96,434,369          
Beginning balance at Mar. 31, 2024 111,654 $ 10,972 379,426 (1,325) (266,207) 683 (11,897)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net (loss) (33,116)       (33,116)    
Other comprehensive income (loss) (934)         67 (1,001)
Issuance of ordinary shares (in shares)   58,709          
Issuance of ordinary shares 0 $ 6 (6)        
Treasury shares (33)     (33)      
Share-based payments 1,525   1,525        
Allocation of accumulated net losses 0   (66,433)   66,433    
Ending balance (in shares) at Jun. 30, 2024   96,493,078          
Ending balance at Jun. 30, 2024 79,095 $ 10,978 314,513 (1,358) (232,890) 750 (12,898)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net (loss) (30,442)       (30,442)    
Other comprehensive income (loss) 3,784         (41) 3,825
Issuance of ordinary shares (in shares)   8,448          
Issuance of ordinary shares 0 $ 1 (1)        
Treasury shares 7     7      
Share-based payments 1,590   1,590        
Allocation of accumulated net losses 0            
Ending balance (in shares) at Sep. 30, 2024   96,501,526          
Ending balance at Sep. 30, 2024 $ 54,034 $ 10,979 $ 316,102 $ (1,351) $ (263,332) $ 709 $ (9,073)